Public Announcement (NASDAQ: IXHL) (ASX

Public Announcement




Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis


...

Related Keywords

New Zealand ,United States ,Australia ,Melbourne ,Victoria ,American ,Australian ,Joel Latham ,Mark Bleackley ,Australian Stock Exchange ,Incannex Healthcare ,Nasdaq ,Incannex Healthcare Limited ,Incannex Healthcare Limited Nasdaq ,Drug Administration ,Edison Group ,Public Announcement ,Healthcare Limited ,Investigational New Drug Application ,Investigational New Drug ,Scientific Officer ,Rialto South Tower ,Patient Reported Outcomes ,Incannex Board ,American Depository Shares ,Securities Litigation Reform Act ,Chief Executive Officer ,Relations Contact ,